The Role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study. (2024). Radiology and Oncology, 58(3), 335-347. https://www.radioloncol.com/index.php/ro/article/view/4413